Proteomic Differences in Normal and Glaucomatous Optic Nerve
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2005 - March 31, 2007
Grant ID
G2005047
Summary
Dr. Bhattacharya believes there are intrinsic differences in protein composition in the optic nerve that put the individuals at increased risk to glaucoma and that protein modifications leads to progression of the disease. The specific aim of this project is to determine the differential protein profile between a normal and glaucomatous optic nerve and to confirm the identity of unique glaucoma-associated proteins. The identification of proteins and protein modifications may serve as markers for individuals predisposed to an increased risk of developing glaucoma. Such information will provide insight into the causes of glaucoma and lead to identification of possible drug targets for glaucoma therapy.
Grantee institution at the time of this grant: Cleveland Clinic Foundation
Related Grants
National Glaucoma Research
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
National Glaucoma Research
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
National Glaucoma Research
Interleukin-10 As a Neuroprotective Factor in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Tatjana Jakobs, MD
Current Organization
The Schepens Eye Research Institute, Mass. Eye and Ear
Interleukin-10 As a Neuroprotective Factor in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Tatjana Jakobs, MD
Current Organization
The Schepens Eye Research Institute, Mass. Eye and Ear